These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
359 related items for PubMed ID: 22486923
21. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients. Bo S, Ciccone G, Rosato R, Villois P, Appendino G, Ghigo E, Grassi G. Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892 [Abstract] [Full Text] [Related]
28. Comparing the efficacy and safety profile of sitagliptin versus glimepiride in patients of type 2 diabetes mellitus inadequately controlled with metformin alone. Srivastava S, Saxena GN, Keshwani P, Gupta R. J Assoc Physicians India; 2012 Mar; 60():27-30. PubMed ID: 22799111 [Abstract] [Full Text] [Related]
29. Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study. Horsdal HT, Mehnert F, Rungby J, Johnsen SP. J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):717-25. PubMed ID: 21536457 [Abstract] [Full Text] [Related]
30. Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus. Kabadi MU, Kabadi UM. Ann Pharmacother; 2003 Nov; 37(11):1572-6. PubMed ID: 14565810 [Abstract] [Full Text] [Related]
32. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes]. André P. Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683 [No Abstract] [Full Text] [Related]
33. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. Mellbin LG, Malmberg K, Norhammar A, Wedel H, Rydén L, DIGAMI 2 Investigators. Eur Heart J; 2008 Jan; 29(2):166-76. PubMed ID: 18156614 [Abstract] [Full Text] [Related]
35. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study. Roumie CL, Hung AM, Greevy RA, Grijalva CG, Liu X, Murff HJ, Elasy TA, Griffin MR. Ann Intern Med; 2012 Nov 06; 157(9):601-10. PubMed ID: 23128859 [Abstract] [Full Text] [Related]
38. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies. Thakkar B, Aronis KN, Vamvini MT, Shields K, Mantzoros CS. Metabolism; 2013 Jul 06; 62(7):922-34. PubMed ID: 23419783 [Abstract] [Full Text] [Related]